Table 9.
Items | Treatments | Significance, p-Value | |||||||
---|---|---|---|---|---|---|---|---|---|
Con | GP3% | GP6% | GP9% | SEM | Con vs. GP | L | Q | C | |
Protein metabolites | |||||||||
TP, g/dL | 3.96 b | 4.18 b | 4.78 a | 4.91 a | 0.108 | <0.001 | <0.001 | 0.57 | 0.04 |
Albumin, g/dL | 2.09 c | 2.32 b | 2.79 a | 2.83 a | 0.046 | <0.001 | <0.001 | 0.02 | 0.002 |
Globulin, g/dL | 1.87 | 1.86 | 1.99 | 2.08 | 0.118 | 0.27 | 0.08 | 0.57 | 0.64 |
Lipid profile | |||||||||
Cholesterol, mg/dL | 158.16 a | 149.25 ab | 139.20 bc | 129.24 c | 4.752 | 0.002 | <0.001 | 0.88 | 0.94 |
Triglycerides, mg/dL | 80.26 a | 72.94 a | 61.21 b | 58.24 b | 3.216 | <0.001 | <0.001 | 0.37 | 0.23 |
HDL, mg/dL | 26.50 c | 33.84 bc | 44.78 ab | 47.14 a | 3.520 | 0.001 | <0.001 | 0.35 | 0.31 |
LDL, mg/dL | 58.2 a | 39.65 b | 39.37 b | 31.91 c | 1.153 | <0.001 | <0.001 | <0.001 | <0.001 |
Hepatic function | |||||||||
AST, mg/dL | 26.80 a | 24.75 b | 22.57 bc | 23.15 c | 0.611 | <0.001 | <0.001 | 0.02 | 0.17 |
ALT, mg/dL | 18.93 a | 15.59 bc | 16.64 ab | 12.99 c | 0.948 | 0.002 | 0.001 | 0.82 | 0.02 |
Antioxidant status | |||||||||
GPx, U/mL | 3.68 c | 3.84 b | 4.85 a | 4.82 a | 0.066 | <0.001 | <0.001 | 0.10 | <0.001 |
MDA, nmol/mL | 39.46 a | 37.65 b | 32.68 c | 30.16 d | 0.774 | <0.001 | <0.001 | 0.54 | 0.05 |
abc Means with different letters within each measurement varied at p < 0.05; SEM = Standard error of the mean. The dietary treatments were a control group (no GP) and experimental diets containing 30, 60, or 90 g GP/kg feed (GP3%, GP6%, and GP9%, respectively).